Logo for Nautilus Biotechnology Inc

Nautilus Biotechnology Investor Relations Material

Latest events

Logo for Nautilus Biotechnology Inc

Q3 2024

Nautilus Biotechnology
Logo for Nautilus Biotechnology

Q3 2024

29 Oct, 2024
Logo for Nautilus Biotechnology

Q2 2024

30 Jul, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Nautilus Biotechnology Inc

Access all reports
Nautilus Biotechnology, Inc. is a life sciences company specializing in the development of a next-generation platform for proteomics research. The company's technology is designed to identify and quantify proteins with high sensitivity, aiming to advance scientific discovery and improve healthcare outcomes. Nautilus focuses on enabling researchers to study the proteome at unprecedented depth and scale, which could support advancements in drug discovery, diagnostics, and personalized medicine. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.